Nationwide Children’s Hospital study identifies potential new pathway for drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children’s Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development. The study appears in PLOS ONE.

More than one-third of drugs on the market work by targeting G protein-coupled receptors that control how cells communicate and function. With many hundreds of members, G protein-coupled receptors are the largest family of signaling receptors throughout the body. Full press release here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

The Ohio State University Comprehensive Cancer Center and Evotec to collaborate on novel cancer therapy | Globe Newswire, December 22, 2014

Explorys continues to experience rapid growth, adds three healthcare IT executives to its leadership team | PRWeb, December 22, 2014

Dayton Children’s stepping up to meet record levels of visits | Xenia Gazette, December 21, 2014

Ohio’s children’s hospitals to split $1M state grant to study abuse in young children | The Columbus Dispatch, December 19, 2014

$1M research grant to the Ohio Children’s Hospital Association to study injuries in children that could indicate child abuse | Ohio Attorney General, December 19, 2014

Nationwide Children’s gene therapy lands TechColumbus investment, Milo Biotechnology | Columbus Business First, December 19, 2014

Interview with Cedarville University School of Pharmacy Dean Marc Sweeney | Pharmacy Times, December 19, 2014

Fathom Healthcare to embrace growth, digital health intervention in 2015 | PR Newswire, December 19, 2014

Cleveland Clinic spins out 71st company, Centerline Biomedical’s 3D surgical platform to reduce radiation exposure during operations | MedCity News, December 18, 2014

Northeast Ohio Medical University (NEOMED) and Mercy Health team up on scholarship program | IndeOnline, December 17, 2014

New distribution partnership between Ganeden Biotech and Grupo Saporiti will increase availability of GanedenBC30 in South America | Ganeden Biotech, December 17, 2014

Sparton acquires Industrial Electronic Devices, makers of ruggedized displays for electronics | Business Wire, December 17, 2014

Columbus downtown building where cancer drugs were once made might be demolished | The Columbus Dispatch, December 17, 2014

Health and Human Services awards Ohio $75 million to implement and test health care payment and service delivery models, improve care, lower costs | Ohio Hospital Association, December 16, 2014

Tedia chairman Elinora Park honored by the Cincinnati Regional Chamber of Commerce | PR Web, December 16, 2014

Cleveland HeartLab is the fastest growing private health care company in the Cleveland metro area according to Inc. | Inc., December 16, 2014

US Endoscopy announces distribution agreement for the EndoRings device | US Endoscopy, December 16, 2014

CincyTech portfolio companies raising $200 million in investor capital by end of 2014 | Cincinnati.com, December 16, 2014

Data presented by independent academic collaborators demonstrate ability of novel Manocept Immunotherapy to kill activated macrophages from KS patients, Macrophage Therapeutics, Navidea Biopharmaceuticals | Business Wire, December 15, 2014

Clinical Research Management (ClinicalRM) announces clinical trial evaluating effectiveness of convalescent plasma therapy for the treatment of Ebola underway in Liberia | PR Newswire, December 15, 2014